Medfinder
Back to blog

Updated: January 15, 2026

Why Is AirDuo So Hard to Find? [Explained for 2026]

Author

Peter Daggett

Peter Daggett

Empty pharmacy shelf with scattered asthma inhalers and magnifying glass

AirDuo RespiClick was discontinued in July 2025. Learn what happened, what's still available, and how to find fluticasone/salmeterol in stock near you.

You went to refill your AirDuo RespiClick inhaler — and found out it's no longer available. No backorder, no timeline. Just gone. If you're one of the thousands of asthma patients who relied on AirDuo, this news can feel alarming. The good news is that your medication isn't truly "gone" — but you do need to know what changed and what your options are.

In this post, we'll break down exactly why AirDuo RespiClick is so hard to find in 2026, what the difference is between the brand and the generic, and what steps you can take right now to keep your asthma controlled.

What Is AirDuo RespiClick?

AirDuo RespiClick is a combination maintenance inhaler containing fluticasone propionate (an inhaled corticosteroid) and salmeterol (a long-acting beta agonist, or LABA). It was approved by the FDA for treating asthma in patients 12 years and older and was used twice daily to prevent asthma symptoms — not to relieve acute attacks.

AirDuo was manufactured by Teva Respiratory and delivered medication through a breath-activated, multidose dry powder inhaler (MDPI) called the RespiClick. It came in three strengths: 55/14 mcg, 113/14 mcg, and 232/14 mcg (fluticasone/salmeterol).

Why Was AirDuo RespiClick Discontinued?

On July 9, 2025, Teva Respiratory officially discontinued distribution of the AirDuo RespiClick brand in the United States. As of that date, Teva stopped selling the brand-name product to wholesalers, meaning no new inventory entered the supply chain. Any AirDuo RespiClick still found at pharmacies in late 2025 represented leftover channel inventory that would eventually be exhausted.

This discontinuation was a business decision by Teva — not a safety issue or an FDA recall. Teva had already discontinued the related AirDuo Digihaler (the smart inhaler version with Bluetooth tracking) in June 2024. By mid-2025, Teva opted to fully exit the brand-name AirDuo product line.

The important distinction: the active ingredients — fluticasone propionate and salmeterol — are not gone. They remain widely available through both the authorized generic and competing brand-name products.

Is the AirDuo Generic Still Available?

Yes. Teva continues to manufacture and distribute an authorized generic of AirDuo RespiClick, sold under the name "Fluticasone Propionate and Salmeterol Inhalation Powder (MDPI)." This is the exact same drug — the same formulation, the same inhaler device, the same active ingredients — just without the AirDuo brand name on the label.

The authorized generic is available in all three strengths (55/14, 113/14, and 232/14 mcg) and is covered by most Medicare and commercial insurance plans. In many cases, insurance plans actually prefer the generic over the brand-name product — which means patients may pay less.

Why Is Fluticasone/Salmeterol Still Hard to Find at Some Pharmacies?

Even though the authorized generic is still being made, patients searching under the "AirDuo" name may get confused results at the pharmacy counter. Several factors contribute to availability challenges in 2026:

  • Name confusion: The brand "AirDuo RespiClick" is discontinued. Pharmacists may not have it under that name, but may have the authorized generic under its chemical name.
  • Stocking patterns: Not every pharmacy carries every inhaler. Large chain pharmacies may carry different stock than independent pharmacies.
  • Prescription specificity: If your prescription says "AirDuo RespiClick" specifically, it may need to be updated by your prescriber to indicate the authorized generic or equivalent.
  • ASHP shortage listing: The American Society of Health-System Pharmacists (ASHP) has tracked fluticasone/salmeterol availability — while the authorized generic is being produced, distribution to individual pharmacies can still vary.

What Should You Do If You Can't Find AirDuo?

Here are the steps to take right now:

  1. Ask your pharmacist about the authorized generic. Request "Fluticasone Propionate/Salmeterol MDPI" — the same drug without the AirDuo label.
  2. Call ahead or use a tool like medfinder. Don't drive to multiple pharmacies blind. medfinder (medfinder.com) contacts pharmacies near you to check which ones have your medication in stock.
  3. Contact your prescriber. Your doctor may need to update your prescription to allow for the authorized generic or switch you to an equivalent ICS/LABA inhaler like Advair, Symbicort, or Breo Ellipta.
  4. Consider a therapeutic alternative. Several other ICS/LABA inhalers contain the same or equivalent active ingredients. See our full guide to AirDuo alternatives.

Will AirDuo RespiClick Come Back?

As of 2026, there is no indication that Teva plans to relaunch the AirDuo RespiClick brand. The discontinuation appears to be permanent. However, the active ingredients remain widely available through the authorized generic and competing products like Advair Diskus, Advair HFA, and Wixela Inhub — all of which contain the same medications (fluticasone and salmeterol) in comparable formulations.

How Can medfinder Help?

If you're struggling to find fluticasone/salmeterol inhalation powder at a pharmacy near you, medfinder can help. You provide your medication, dosage, and location — then medfinder calls pharmacies in your area to find out which ones have it in stock. Results are sent directly to you by text. No more driving from pharmacy to pharmacy empty-handed.

For more tips on locating fluticasone/salmeterol at pharmacies near you, read our guide to finding AirDuo in stock. If your doctor has talked about switching inhalers, see our guide to AirDuo alternatives for 2026.

Frequently Asked Questions

The brand-name AirDuo RespiClick was discontinued by Teva on July 9, 2025. However, the authorized generic — Fluticasone Propionate and Salmeterol Inhalation Powder (MDPI) — is still being manufactured by Teva and is available at most pharmacies. Ask your pharmacist for the authorized generic by name.

Teva discontinued AirDuo RespiClick in July 2025 as a business decision — not due to a safety issue or FDA recall. Teva had already discontinued the AirDuo Digihaler in June 2024. The authorized generic of AirDuo RespiClick remains available.

The authorized generic is called Fluticasone Propionate and Salmeterol Inhalation Powder (MDPI), also made by Teva. It is the exact same medication and inhaler device as AirDuo RespiClick — just without the brand name. It comes in the same three strengths: 55/14 mcg, 113/14 mcg, and 232/14 mcg.

First, ask your pharmacist for the authorized generic (Fluticasone Propionate/Salmeterol MDPI). If that isn't available, contact your prescriber to discuss switching to an equivalent ICS/LABA inhaler such as Advair, Symbicort, or Breo Ellipta. You can also use medfinder.com to check which nearby pharmacies have your medication in stock.

Yes. Fluticasone propionate/salmeterol is the active ingredient combination in AirDuo RespiClick. The authorized generic uses the same formulation and the same RespiClick inhaler device. Advair Diskus and Wixela Inhub also contain fluticasone/salmeterol but use different inhaler devices and slightly different doses.

Medfinder Editorial Standards

Medfinder's mission is to ensure every patient gets access to the medications they need. We are committed to providing trustworthy, evidence-based information to help you make informed health decisions.

Read our editorial standards

Patients searching for AirDuo RespiClick also looked for:

30,313 have already found their meds with Medfinder.

Start your search today.

30K+
5-star ratingTrusted by 30,313 Happy Patients
      What med are you looking for?
⊙  Find Your Meds
99% success rate
Fast turnaround time
Never call another pharmacy

Need this medication?